NCT05572476 2024-06-05
LURBIMUNE
Institut Bergonié
Phase 2 Withdrawn
Clinical Trials
13 trialsNCT05411679 2023-06-12
EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung Cancer
Ellipses Pharma
Phase 2 Withdrawn
NCT05582031 2023-06-07
REFIT-MSS
Translational Research in Oncology
Phase 2 Withdrawn
NCT02542137 2019-03-21
Abscopal Effect for Metastatic Small Cell Lung Cancer
Zhejiang Provincial People's Hospital
Phase 2 Withdrawn
NCT03266159 2017-12-08
A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid Tumors
GlaxoSmithKline
Phase 2 Withdrawn
NCT02876081 2017-09-11
THEN
Fondation Hôpital Saint-Joseph
Phase 2 Withdrawn
NCT02425072 2017-08-10
NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer
University of Kentucky
Phase 2 Withdrawn
NCT01640847 2017-02-07
MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases
Imunon
Phase 2 Withdrawn
NCT00104754 2016-07-20
Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Withdrawn
NCT00755157 2015-10-07
Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer
University Hospital of Crete
Phase 2 Withdrawn
NCT00006374 2014-01-15
Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Case Comprehensive Cancer Center
Phase 2 Withdrawn
NCT00916669 2013-05-08
A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)
Massachusetts General Hospital
Phase 2 Withdrawn
NCT00472771 2012-02-09
INNO-206 in Patients With Small Cell Lung Cancer (SCLC)
CytRx
Phase 2 Withdrawn